[{"innerBlocks":[],"name":"core\/freeform","postId":3646,"blockType":{"name":"core\/freeform","keywords":[],"attributes":{"content":{"type":"string","source":"raw"},"lock":{"type":"object"}},"providesContext":[],"usesContext":[],"selectors":[],"supports":{"className":false,"customClassName":false,"reusable":false},"styles":[],"variations":[],"apiVersion":3,"title":"Classic","description":"Use the classic WordPress editor.","category":"text"},"originalContent":"The healthcare industry is in the midst of a new era in computing, according to Ginni Rometty, chairman, president and CEO of IBM. Cognitive computing\u2014systems that learn\u2014will profoundly change medicine and the way that care is delivered to patients.

\u201cWe\u2019re in a moment where we can actually transform many parts of healthcare,\u201d said Rometty in an opening keynote address on Monday at the HIMSS17 conference in Orlando. \u201cHealthcare will be the industry impacted more than any other,\u201d adding that \u201ccognitive as an era could usher in what people call a Golden Age, but it\u2019s only if we shape it wisely.\u201d

As CEO of IBM since 2012, she has worked to transform the technology behemoth into a cognitive solutions and cloud platform company. Rometty noted that two years ago at HIMSS15, IBM launched Watson Health, the first commercially available cognitive computing capability delivered through the cloud to analyze high volumes of data, understand complex questions posed in natural language, and propose evidence-based answers.

Rometty, who has been with Big Blue since 1981, said that Watson Health is meant to help physicians, researchers, insurers and patients use big data, analytics and mobile technology to achieve better health outcomes, calling the business unit IBM\u2019s \u201cmoonshot\u201d in healthcare.

According to Rometty, health IT professionals face three key architecture decisions in the next one to two years\u2014cloud, data and artificial intelligence\u2014that will impact the global healthcare industry over the next two decades.

\u201cYou\u2019re going to pick a cloud, you\u2019re going to pick a data platform, and you\u2019re going to pick an AI platform,\u201d she argued. \u201cYou\u2019re going to have to have a cloud that is optimized for all this cognitive data.\u201d

IBM is hoping that healthcare organizations tap into this cloud-based data to take previously disparate data sets\u2014structured and unstructured\u2014combining them together to create unique insights.

Also See<\/b>: Providers need new tools to make sense of unstructured data<\/a>

\u201cIt\u2019s not enough to just think of artificial intelligence or natural language\u2014you need vision, you need deep learning, you need many more algorithms,\u201d said Rometty.

The 105-year-old technology behemoth has bet its future on Watson and its use of natural language processing and machine learning to provide actionable insights from large amounts of unstructured data. In addition, IBM\u2019s Watson Platform for Health Cloud (formerly Watson Health Core cloud platform) is designed to help store, sort and analyze both structured and unstructured data as a service offering.

At HIMSS17, IBM announced expanded capabilities for the Watson Platform for Health Cloud and a specialized Watson Health Consulting Services unit dedicated to helping clients and partners across the healthcare ecosystem capture the business opportunity of cognitive computing in medicine.

\u201cA cloud that is built for big data, built for security and one\u2014by the way\u2014that\u2019s going to have to be hybrid because otherwise, you can\u2019t connect such a wide ecosystem, whether it\u2019s an academic center or a community hospital,\u201d Rometty added. \u201cIt\u2019s also got to be an open platform, because this is an industry all about innovation that doesn\u2019t come from one person\u2014it\u2019s about an ecosystem of people.\u201d

When it comes to healthcare innovation, she said that Watson is making ground-breaking discoveries. Case in point: Barrow Neurological Institute in Phoenix, the world's largest neurological disease treatment and research institution, used IBM\u2019s cognitive system to help its scientists identify five genes associated with amyotrophic lateral sclerosis (ALS) that had never before been linked to the disease.

Overall, Rometty boasted that IBM Watson and its cloud offering is \u201cthe<\/i> AI platform for business\u201d serving 45 countries, 20 industries, nine languages and 1 billion consumers by the end of 2017. In particular, Watson for Oncology, which analyzes the meaning and context of structured and unstructured data in clinical notes and reports, is \u201crolling out across hospitals in China, India, Thailand and Finland,\u201d she said.

In the area of precision medicine, Rometty argued that Watson can help clinicians quickly sift through this kind of data providing insights on cancer-causing mutations. She pointed to the University of North Carolina\u2019s Lineberger Comprehensive Cancer Center as an example of the \u201cgreat promise\u201d of the cognitive computing era.

\u201c60 Minutes<\/i> did a segment not long ago on this,\u201d Rometty said. \u201cIn a thousand (patent) cases, and these were not standard cases, on almost 100 percent of the cases, doctors and Watson matched. But, in 30 percent, Watson found more clinically actionable items. That, to me, is what this is all about.\u201d

Precision medicine in this cognitive era is \u201cjust now going to come alive,\u201d she concluded. \u201cIt\u2019s mainstream, and it\u2019s here.\u201d","saveContent":"The healthcare industry is in the midst of a new era in computing, according to Ginni Rometty, chairman, president and CEO of IBM. Cognitive computing\u2014systems that learn\u2014will profoundly change medicine and the way that care is delivered to patients.

\u201cWe\u2019re in a moment where we can actually transform many parts of healthcare,\u201d said Rometty in an opening keynote address on Monday at the HIMSS17 conference in Orlando. \u201cHealthcare will be the industry impacted more than any other,\u201d adding that \u201ccognitive as an era could usher in what people call a Golden Age, but it\u2019s only if we shape it wisely.\u201d

As CEO of IBM since 2012, she has worked to transform the technology behemoth into a cognitive solutions and cloud platform company. Rometty noted that two years ago at HIMSS15, IBM launched Watson Health, the first commercially available cognitive computing capability delivered through the cloud to analyze high volumes of data, understand complex questions posed in natural language, and propose evidence-based answers.

Rometty, who has been with Big Blue since 1981, said that Watson Health is meant to help physicians, researchers, insurers and patients use big data, analytics and mobile technology to achieve better health outcomes, calling the business unit IBM\u2019s \u201cmoonshot\u201d in healthcare.

According to Rometty, health IT professionals face three key architecture decisions in the next one to two years\u2014cloud, data and artificial intelligence\u2014that will impact the global healthcare industry over the next two decades.

\u201cYou\u2019re going to pick a cloud, you\u2019re going to pick a data platform, and you\u2019re going to pick an AI platform,\u201d she argued. \u201cYou\u2019re going to have to have a cloud that is optimized for all this cognitive data.\u201d

IBM is hoping that healthcare organizations tap into this cloud-based data to take previously disparate data sets\u2014structured and unstructured\u2014combining them together to create unique insights.

Also See<\/b>: Providers need new tools to make sense of unstructured data<\/a>

\u201cIt\u2019s not enough to just think of artificial intelligence or natural language\u2014you need vision, you need deep learning, you need many more algorithms,\u201d said Rometty.

The 105-year-old technology behemoth has bet its future on Watson and its use of natural language processing and machine learning to provide actionable insights from large amounts of unstructured data. In addition, IBM\u2019s Watson Platform for Health Cloud (formerly Watson Health Core cloud platform) is designed to help store, sort and analyze both structured and unstructured data as a service offering.

At HIMSS17, IBM announced expanded capabilities for the Watson Platform for Health Cloud and a specialized Watson Health Consulting Services unit dedicated to helping clients and partners across the healthcare ecosystem capture the business opportunity of cognitive computing in medicine.

\u201cA cloud that is built for big data, built for security and one\u2014by the way\u2014that\u2019s going to have to be hybrid because otherwise, you can\u2019t connect such a wide ecosystem, whether it\u2019s an academic center or a community hospital,\u201d Rometty added. \u201cIt\u2019s also got to be an open platform, because this is an industry all about innovation that doesn\u2019t come from one person\u2014it\u2019s about an ecosystem of people.\u201d

When it comes to healthcare innovation, she said that Watson is making ground-breaking discoveries. Case in point: Barrow Neurological Institute in Phoenix, the world's largest neurological disease treatment and research institution, used IBM\u2019s cognitive system to help its scientists identify five genes associated with amyotrophic lateral sclerosis (ALS) that had never before been linked to the disease.

Overall, Rometty boasted that IBM Watson and its cloud offering is \u201cthe<\/i> AI platform for business\u201d serving 45 countries, 20 industries, nine languages and 1 billion consumers by the end of 2017. In particular, Watson for Oncology, which analyzes the meaning and context of structured and unstructured data in clinical notes and reports, is \u201crolling out across hospitals in China, India, Thailand and Finland,\u201d she said.

In the area of precision medicine, Rometty argued that Watson can help clinicians quickly sift through this kind of data providing insights on cancer-causing mutations. She pointed to the University of North Carolina\u2019s Lineberger Comprehensive Cancer Center as an example of the \u201cgreat promise\u201d of the cognitive computing era.

\u201c60 Minutes<\/i> did a segment not long ago on this,\u201d Rometty said. \u201cIn a thousand (patent) cases, and these were not standard cases, on almost 100 percent of the cases, doctors and Watson matched. But, in 30 percent, Watson found more clinically actionable items. That, to me, is what this is all about.\u201d

Precision medicine in this cognitive era is \u201cjust now going to come alive,\u201d she concluded. \u201cIt\u2019s mainstream, and it\u2019s here.\u201d","order":0,"get_parent":{},"attributes":[],"attributesType":{"content":{"type":"string","source":"raw"},"lock":{"type":"object"}},"dynamicContent":""}]

Healthcare industry leaps into the cognitive era, IBM’s Ginni Rometty says

More for you